108829 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Cells modified by introduction of foreign genetic material; Fused cells, e.g. hybridomas Animal cells
Sub-classes:PERSONALIZED MUC1-C INDUCED PLURIPOTENT STEM CELL AND DENDRITIC CELL BASED VACCINES
#2METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER
#3ANTI-IL1RAP ANTIBODIES AND METHODS OF USE THEREOF
#4ANTI-NOTCH3 ANTIBODIES
#5HUMANIZED IL-6 AND IL-6 RECEPTOR
#6VERO CELL LINES STABLY EXPRESSING HSV ICP0 PROTEIN
#7GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION HAVE IMPROVED FUNCTIONALITY AND PERSISTENCE
#8METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER
#9IMPROVED MEDIA FOR THE EXPRESSION OF RECOMBINANT VITAMIN K-DEPENDENT PROTEINS
#10GENETICALLY MODIFIED MICE FOR PREPARING ANTIBODIES AND PREPARATION METHOD THEREFOR
#11Use of constitutively active variants of growth factor receptors as selection markers for the generation of stable producer cell lines
#12DNA SEQUENCE MODIFICATION-BASED GENE DRIVE
#13POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS
#14MAMMALIAN ARTIFICIAL CHROMOSOME VECTOR HAVING HUMAN IMMUNOGLOBULIN HEAVY CHAIN LOCUS COMPRISING MODIFIED D-REGION, AND CELL OR NON-HUMAN ANIMAL RETAINING THE VECTOR
#15PROTEIN PRODUCER CELLS MADE BY FUSING CELLS TOGETHER AND SELECTING FOR HIGH LEVEL EXPRESSION OF A TRANSGENE
#16ANTI-HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF
#17ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
#18MODIFICATION OF IMMUNE CELLS FOR REDUCING TOXICITY AND USES THEREOF IN ADOPTIVE CELL THERAPY
#19METHOD FOR PRODUCING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN THE SAME
#20Method For Differentiating Pluripotent Stem Cells Into Desired Cell Type
#21Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#22METHOD FOR PRODUCING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN THE SAME
#23AXL-SPECIFIC ANTIBODIES AND USES THEREOF
#24PERSONALIZED FUSION CELL VACCINES
#25ANTI-L1-CAM ANTIBODIES AND USES THEREOF
#26COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM
#27GENE THERAPY
#28Cell transfection by precise mechanical membrane disruption
#29CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#30Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#31METHOD FOR SELECTING CELL
#32Methods of permeabilizing the blood brain barrier
#33SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY
#34Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof
#35Antibody binding specifically to MUC1 and use thereof
#36UNIVERSAL DONOR CELLS
#37Antibody binding specifically to MUC1 and use thereof
#38COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION
#39SCREENING METHOD FOR OFFENSIVE ODOR-SUPPRESSING MATERIAL
#40FRAGRANCE OR FLAVOR COMPOSITION
#41CONTIGUITY PARTICLE FORMATION AND METHODS OF USE
#42MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES
#43CHIMERIC CELLS COMPRISING DENDRITIC CELLS AND ENDOTHELIAL CELLS RESEMBLING TUMOR ENDOTHELIUM
#44ANTIBODIES FOR THE DIAGNOSIS AND TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
#45USE OF ION CONCENTRATIONS TO INCREASE THE PACKAGING EFFICIENCY OF RECOMBINANT ADENO-ASSOCIATED VIRUS
#46HYBRIDOMA, METHOD FOR MAKING THE SAME, MONOCLONAL ANTIBODY, AND METHOD FOR MAKING THE SAME
#47VECTORS AND EXPRESSION SYSTEMS FOR PRODUCING RECOMBINANT PROTEINS
#48CELL LINES FOR HIGH LEVEL PRODUCTION OF PROTEIN
#49HYBRID YEAST CELL LINES FOR HIGH LEVEL PRODUCTION OF RECOMBINANT PROTEIN
#50INDUCED ACTIVATION IN DENDRITIC CELLS
#51Antibody or chimeric antigen receptor which targets Claudin 18.2
#52Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
#53Collagen Type X Alpha-1 Assay
#54CAGED-DEGRON-BASED MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME
#55T CELL RECEPTORS SPECIFIC TO B-CELL MATURATION ANTIGEN FOR TREATMENT OF CANCER
#56Method of treating asthma with anti-IL1RAP antibodies
#57Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#58Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#59Ultra-long acting insulin-Fc fusion proteins and methods of use
#60Humanized IL-6 and IL-6 receptor
#61Antibody binding to carbonic anhydrase and use thereof
#62MUSCULAR DYSTROPHY CHIMERIC CELLS AND METHOD FOR TREATING MUSCULAR DYSTROPHIES
#63Universal donor cells
#64Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#65Gene and cell therapy using cell fusion technology
#66Mitochondria isolation
#67Ultra-long acting insulin-Fc fusion proteins and methods of use
#68ENHANCED PRODUCTION OF IMMUNOGLOBULINS
#69Antibody binding to chondroitin sulfate proteoglycan 5
#70Human serum albumin mutant
#71Polypeptides, nucleic acid molecules, compositions, and related methods
#72METHODS FOR MAKING AND USING MODIFIED OOCYTES
#73Anti-notch3 antibodies
#74METHOD FOR PRODUCING ANIMAL CELL CONTAINING DNA OF INTEREST USING MICRONUCLEATE CELL FUSION METHOD
#75COMPOSITIONS AND METHODS FOR SOMATIC CELL REPROGRAMMING AND MODULATING IMPRINTING
#76Method for Obtaining Haploid Cells
#77Antibody binding specifically to MUC1 and use thereof
#78Mutant MYC fusion polypeptides and uses thereof
#79Universal donor cells
#80Universal donor cells
#81Enhancing activity of CAR T cells by co-introducing a bispecific antibody
#82Compositions comprising cyclic peptides derived from an A-beta peptide
#83Optical-quality surface that imparts spatial control of macrophage fusion
#84Method for differentiating pluripotent stem cells into desired cell type
#85Methods and Materials for Producing Hybrid Cell Lines
#86Modification of immune cells for reducing toxicity and uses thereof in adoptive cell therapy
#87Serologic test for therapy control of HPV16 positive carcinoma
#88Cell Mass Fusion Method
#89Use of constitutively active variants of growth factor receptors as selection markers for the generation of stable producer cell lines
#90Anti-survivin antibodies for cancer therapy
#91Precise mechanical disruption for intracellular delivery to cells and small organisms
#92SYNNOTCH RECEPTOR-REGULATED EXPRESSION OF IL12
#93Antibodies specific for claudin 6 (CLDN6)
#94Gene and cell therapy using cell fusion technology
#95Method for preparing porcine fibroblasts with both CD163 gene and CD13 gene being knocked-out
#96AXL-specific antibodies and uses thereof
#97Multi-Chimeric Cell and Therapy for Transplantation and Treatment of Immune Deficiencies and Genetic Disorders
#98Human serum albumin mutant
#99Compositions and methods for induced brown fat differentiation
#100INDUCED ACTIVATION IN DENDRITIC CELLS
#101METHODS OF REPROGRAMMING ANIMAL SOMATIC CELLS
#102Vero cell lines stably expressing HSV ICP0 protein
#103Method for producing DNA-edited eukaryotic cell, and kit used in the same
#104Anti-IL1RAP antibodies
#105BCMA and CD3 bispecific T cell engaging antibody constructs
#106Recombinant glycoproteins with reduced antennary fucosylation
#107Antibody binding specifically to MUC1 and use thereof
#108Anti-GPR20 antibody
#109Humanized IL-6 and IL-6 receptor
#110DNA plasmids for the fast generation of homologous recombination vectors for cell line development
#111Gene therapy
#112PQQ-sGDH mutant, polynucleotide and glucose detection biosensor
#113COMPOSITIONS AND METHODS RELATING TO MYOMIXER-PROMOTED MUSCLE CELL FUSION
#114Compositions and methods relating to myomaker-induced muscle cell fusion
#115Contiguity particle formation and methods of use
#116Folate receptor 1 antibodies and immunoconjugates and uses thereof
#117PERSONALIZED VACCINES
#118Methods for making and using modified oocytes
#119Hybrid cell lines for high level production of a target protein
#120METHOD FOR SELECTING CELL
#121Porcine cell line for virus production
#122Metabolically competent cells, methods of making, and uses thereof
#123Generation of human oocytes
#124VIRUS INFECTION MODEL, PREPARATION METHOD THEREFOR, AND UTILIZATION THEREOF
#125DNA Plasmids for the Fast Generation of Homologous Recombination Vectors for Cell Line Development
#126Antibody binding to carbonic anhydrase and use thereof
#127COMPOSITIONS AND METHODS OF TREATING CANCER
#128Antibodies against HMB1, and composition comprising same for treating or preventing alzheimer's disease
#129Enveloped virus resistant to complement inactivation for the treatment of cancer
#130Compositions and Methods for Inhibiting Stem Cell Aging
#131Chimeric antigen receptors and uses thereof
#132Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#133Anti-survivin antibodies for cancer therapy
#134Serologic test for therapy control of HPV16 positive carcinoma
#135Host Cell Modification with Artificial Endosymbionts
#136Induction of differentiation of induced pluripotent stem cells into intestinal epithelial cells
#137VCN enhancer compositions and methods of using the same
#138IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#139Phase transfer of a cargo laden scaffold
#140Media for the expression of recombinant vitamin K-dependent proteins
#141Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#142Host cells with artificial endosymbionts
#143DNA sequence modification-based gene drive
#144Method for producing platelets using reciprocating stirring device
#145EFFICIENT AND SAFE TRANSPOSON INTEGRATION SYSTEM AND USE THEREOF
#146CXCR6-transduced T cells for targeted tumor therapy
#147Human serum albumin mutant
#148COMPOSITIONS AND MULTIPLEXED SYSTEMS FOR COUPLED CELL-FREE TRANSCRIPTION-TRANSLATION AND PROTEIN SYNTHESIS AND METHODS FOR USING THEM
#149Method of deriving lacrimal gland epithelial cells from ES cells and other stem cells
#150Anti-NOTCH3 antibodies
#151Muscular dystrophy chimeric cells and method for treating muscular dystrophies
#152REGULATORS OF NFAT
#153FLUORESCENT PROTEIN
#154Gene and cell therapy using cell fusion technology
#155Device and use thereof in cell experiments in vitro
#156Method for producing myocardial cells using synthetic peptide
#157Method of removing pluripotent cells from culture
#158Method for differentiating pluripotent stem cells into desired cell type
#159Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
#160Disease model pig exhibiting stable phenotype, and production method thereof
#161METHOD FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS
#162COMPOSITIONS AND METHODS OF TREATING ACUTE MYELOID LEUKEMIA
#163Monoclonal anti-GPC-1 antibodies and uses thereof
#164Optical-quality surface that imparts spatial control of macrophage fusion
#165Enhancing activity of CAR T cells by co-introducing a bispecific antibody
#166Compound for identifying pluripotent cells
#167Host cell modification with artificial endosymbionts
#168Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration
#169Folate receptor 1 antibodies and immunoconjugates and uses thereof
#170Materials and methods to enhance hematopoietic stem cells engraftment procedures
#171Methods and compositions for generating a mouse
#172Antibodies, pharmaceutical compositions and methods
#173Host cells with artificial endosymbionts
#174Enhanced production of immunoglobulins
#175BCMA and CD3 bispecific T cell engaging antibody constructs
#176Induced activation in dendritic cells
#177METHODS OF REPROGRAMMING ANIMAL SOMATIC CELLS
#178Immunoassay for the detection of procalcitonin
#179Methods for making and using modified oocytes
#180Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide
#181Thymidylate kinase fusions and uses thereof
#182Hybridoma cell lines (My-C-cC0C2-259-1 A4) and use thereof for producing a monoclonal antibody against human cardiac myosin binding protein C (C-protein, MYBPC3, cMyBP-C or My-C)
#183Red-shifted opsin molecules and uses thereof
#184Fermentation systems
#185Host cell modification with artificial endosymbionts
#186Eukaryotic cells with artificial endosymbionts for multimodal detection
#187Host cells with artificial endosymbionts
#188Cardiac, mesenchymal and endothelial progenitor cell (CPC) chimeras and methods for making and using them
#189Methods and compositions for generating a mouse
#190ES Cell-Derived Mice From Diploid Host Embryo Injection
#191Microfluidic cell culture
#192Generation of patient-specific differentiated cell types by epigenetic induction
#193Medium for high performance mammalian fed-batch cultures
#194Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 and their use
#195Method for preparing of endothelial cells by transformation (transdifferentiation) of adult fibroblast, and use thereof
#196reisigl diacylglycerol acyltransferase gene sequence and use thereof
#197Eukaryotic cells with artificial endosymbionts for multimodal detection
#198Anti-Notch3 antibodies
#199Compositions and methods relating to myomaker-induced muscle cell fusion
#200Correctly folded etanercept composition
#201Folate receptor 1 antibodies and immunoconjugates and uses thereof
#202Folate receptor 1 antibodies and immunoconjugates and uses thereof
#203Folate receptor 1 antibodies and immunoconjugates and uses thereof
#204FUSION MIXTURE
#205Folate receptor 1 antibodies and immunoconjugates and uses thereof
#206Regulators of NFAT
#207Materials and methods to enhance hematopoietic stem cells engraftment procedures
#208Compositions and methods for treating or preventing conditions and diseases associated with
#209Induced activation in dendritic cells
#210Eukaryotic cells with artificial endosymbionts for multimodal detection
#211Host cells with artificial endosymbionts
#212Method for inducing fusion of dendritic cell with tumour cell
#213Methods of reprogramming animal somatic cells
#214Generation of patient-specific differentiated cell types by epigenetic induction
#215METHOD FOR REPLICATING HCV IN VITRO
#216Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#217Kit for diagnosing malignant melanoma
#218Red-shifted opsin molecules and uses thereof
#219Host cells with artificial endosymbionts
#220TUMOR-INITIATING CELLS AND METHODS OF USE
#221ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells
#222RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof
#223Host cell modification with artificial endosymbionts
#224Epigenetic induction of human patient-specific self-propagating dopaminergic neuron cell
#225Materials and methods to enhance hematopoietic stem cells engraftment procedures
#226Human pluripotent embryonic stem cells produced by nuclear transfer using a somatic cell nucleus treated with HVJ-E extract and an oocyte from a donor cycle that produced 15 or fewer oocytes
#227Methods for making and using modified oocytes
#228Composition for a mitotic remodeling of chromosomes
#229Perfusion method for manufacturing etanercept
#230Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
#231Transgenic therapeutic stem cells and methods for their use and manufacture
#232Use of cellular extracts for obtaining pluripotent stem cells
#233Thermoplastic resin composition for impact absorbing member and method for producing same
#234Thymidylate kinase fusions and uses thereof
#235Host cells with artificial endosymbionts
#236Induced activation in dendritic cells
#237METHOD OF CREATING AND SORTING FUSED CELLS
#238METHODS FOR MAKING AND USING REPROGRAMMED HUMAN SOMATIC CELL NUCLEI AND AUTOLOGOUS AND ISOGENIC HUMAN STEM CELLS
#239Sulfur-containing amino acid derivative
#240INACTIVATED STAPHYLOCOCCAL WHOLE-CELL VACCINE
#241Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming
#242Human long pentraxin 3 expression system and uses thereof
#243Stem Cell Fusion Model of Carcinogenesis
#244DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
#245Stem cell fusion model of carcinogenesis
#246Marrow stem cell and pancreatic β cell fusion cell useful for the treatment of diabetes
#247Red-shifted opsin molecules and uses thereof
#248Methods of generating cells exhibiting phenotypic plasticity
#249Methods for mitochondrial DNA replacement in oocytes
#250Compositions and methods for induced brown fat differentiation
#251Polypeptides for Specific Targeting to Otx2 Target Cells
#252Folate receptor 1 antibodies and immunoconjugates and uses thereof
#253Materials and methods to enhance hematopoietic stem cells engraftment procedures
#254Generation of patient-specific differentiated cell types by epigenetic induction
#255Compositions and methods for treating or preventing conditions and diseases associated with
#256Simplified method for partial genetic and epigenetic reprogramming of cells using siRNA specific for a heterochromatin protein 1
#257Regulators of NFAT
#258Method for producing induced pluripotent stem cells with high efficiency and induced poluripotent stem cells prouced thereby
#259Generation of patient-specific differentiated cell types by epigenetic induction
#260Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology
#261Heat shock protein GP96 vaccination and methods of using same
#262Methods of Reprogramming Animal Somatic Cells
#263REPROGRAMMING NORMAL AND CANCEROUS HUMAN CELL LINES INTO HUMAN INDUCED POLURIPOTENT STEM CELLS BY CO-ELECTROPORATION WITH LIVING XENOPUS LAEVIS FROG OOCYTES
#264METHODS FOR PROMOTING FUSION AND REPROGRAMMING OF SOMATIC CELLS
#265Thymidylate kinase fusions and uses thereof
#266DIFFERENTIATED IMMORTALISED CELL LINES CAPABLE OF PRODUCING ALBUMIN AND BLOOD COAGULATION FACTORS, METHODS OF PREPARING THEREOF FROM A LEUKAEMIA CELL LINE AND USES THEREOF
#267METHOD FOR REPROGRAMMING DIFFERENTIATED CELLS
#268METHODS FOR IMPROVEMENT OF BIRTH RATES IN CANIDAE ON SOMATIC CELL NUCLEAR TRANSFER
#269T Cell Hybridomas And Related Compositions And Methods For Assaying And Modulating T Cell Receptor-Mediated Immune Responses
#270STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28
#271DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
#272TUMOR/B-CELL HYBRID CELLS AND USES THEREOF
#273Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same
#274Isolated stem cell comprising a Xic flanking region transgene
#275Inactivated staphylococcal whole-cell vaccine
#276Use of a cellular extract for a mitotic remodeling of chromosomes
#277Methods of Reprogramming Animal Somatic Cells
#278Tumor-initiating cells and methods of use
#279Hybrid cells for treating cancer patients
#280COMPOSITION AND METHOD FOR ENHANCING CELL GROWTH AND CELL FUSION
#281Marrow stem cell and pancreatic beta cell fusion cell useful for the treatment of diabetes
#282BIOLOGICALLY EXCITABLE CELLS
#283METHOD FOR PRODUCTION OF ANTIGEN-SPECIFIC HYBRIDOMA USING ARTIFICIAL LYMPH NODE WITH GOOD EFFICIENCY
#284ES Cell-Derived Mice From Diploid Host Embryo Injection
#285Stable neural stem cell lines
#286Regulators of NFAT
#287METHODS FOR MAKING AND USING REPROGRAMMED HUMAN SOMATIC CELL NUCLEI AND AUTOLOGOUS AND ISOGENIC HUMAN STEM CELLS
#288Cytoplasm of Eukaryotic cells for reprogramming of somatic cells, healing, repairing and therapeutic applications
#289Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
#290Combination therapy of hybrid cells with BCG injection for treating Cancer Patients
#291Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
#292Method Of Genotypically Modifying Cells By Administration Of RNA
#293Stem cell fusion model of carcinogenesis
#294Induced activation in dendritic cells
#295Biological Materials and Uses Thereof
#296Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
#297Method for making homozygous genetic modifications
#298Conditioned culture media
#299De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
#300Method for making genetic modifications